Cangrelor
id:
cangrelor-260-12867923
title:
Cangrelor
text:
Cangrelor, sold under the brand name Kengreal among others, is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. Poor interim results led to the abandonment of the two CHAMPION clinical trials in mid-
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Cangrelor
date created:
date modified:
2024-03-03T05:23:16Z
main entity:
{"identifier":"Q3655338","url":"https://www.wikidata.org/entity/Q3655338"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/88/Cangrelor_structure.svg","width":512,"height":213}
fields total:
13
integrity:
15